The downgrade is based on a number of factors, including OVGH’s large operating losses, negative cash flow and significant recent liquidity declines.
The outlook is negative, reflecting OVGH’s risks of breaching a covenant and debt acceleration or further liquidity decline if operating losses continue at the current pace.
More articles on healthcare finance:
Beauty retailer replaces Tenet on S&P 500
ADR limits & denials: 4 observations from Craneware’s Jeff St. Vrain
Jefferson’s neuroscience institute gets boost with $20M donation
